Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nanobiotix SA (GB:0QAV)
LSE:0QAV
Holding GB:0QAV?
Track your performance easily
0QAV Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€3.86 - €9.39
Previous Close€4.63
Volume271.00
Average Volume (3M)2.60K
Market Cap
€216.84M
Enterprise Value€179.38M
Total Cash (Recent Filing)€41.40M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta0.99
Next Earnings
Nov 06, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.07
Shares Outstanding34,825,872
10 Day Avg. Volume727
30 Day Avg. Volume2,603
Standard Deviation0.28
R-Squared0.03
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)0.87
Price to Sales (P/S)46.47
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€16.00Price Target Upside245.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Nanobiotix News
PremiumPress Releases
Voting Rights and Shares Capital of the Company
PremiumPress Releases
Voting Rights and Shares Capital of the Company
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00% Mutual Funds
0.19% Other Institutional Investors
99.81% Public Companies and
Individual Investors
0QAV FAQ
What was Nanobiotix SA’s price range in the past 12 months?
Nanobiotix SA lowest share price was €3.86 and its highest was €9.39 in the past 12 months.
What is Nanobiotix SA’s market cap?
Currently, no data Available
When is Nanobiotix SA’s upcoming earnings report date?
Nanobiotix SA’s upcoming earnings report date is Nov 06, 2024 which is in 59 days.
How were Nanobiotix SA’s earnings last quarter?
Nanobiotix SA released its earnings results on Sep 04, 2024. The company reported -€0.21 earnings per share for the quarter, the consensus estimate of -€0.21 by €0.
Is Nanobiotix SA overvalued?
According to Wall Street analysts Nanobiotix SA’s price is currently Undervalued.
Does Nanobiotix SA pay dividends?
Nanobiotix SA does not currently pay dividends.
What is Nanobiotix SA’s EPS estimate?
Nanobiotix SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nanobiotix SA have?
Nanobiotix SA has 47,133,327 shares outstanding.
What happened to Nanobiotix SA’s price movement after its last earnings report?
Nanobiotix SA reported an EPS of -€0.21 in its last earnings report, expectations of -€0.21. Following the earnings report the stock price went down -5.328%.
Which hedge fund is a major shareholder of Nanobiotix SA?
Currently, no hedge funds are holding shares in GB:0QAV
---
Nanobiotix Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€16.00 (245.57% Upside)
€16.00 (245.57% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
57.10%
Trailing 12-Months
Company Description
Nanobiotix SA
Nanobiotix SA is a late-stage clinical company engaged in developing and selling nanomedicine for the treatment of cancer. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. The company's products include NBTXR3, a preclinical research program for cancer immunotherapies.
---
0QAV Stock 12 Month Forecast
Average Price Target
€16.00
▲(245.57% Upside)
Technical Analysis
Best Analysts Covering 0QAV
1 Year
1 Year Success Rate
3/6 ratings generated profit
1 Year Average Return
+48.05%
reiterated a buy rating 3 months ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +48.05% per trade.
---